Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Respiratory Aspiration 1Radiation Pneumonitis 1Papillomavirus Infections 1Lung Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Deglutition Disorders 1Carcinoma in Situ 1Bronchiolitis Obliterans Syndrome 1

Interventions

Magnetic Resonance Imaging 2Interferon beta-1b 2Electrocardiography 2Diphenhydramine 2Acetaminophen 2valrubicin 1pembrolizumab 1fludarabine phosphate 1fludarabine 1durvalumab 1dodecyl maltoside 1apaziquone 1aldesleukin 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Proflavine 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Nicotine Replacement Therapy 1Meperidine 1Mastectomy, Subcutaneous 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Imiquimod 1Hydroxyzine 1Histamine Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma in Situ × Respiratory Function Tests × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡